fbpx
February 3, 2021

RAP Device Cleared for Short-term Improvement in Cellulite RAP Device Cleared for Short-term Improvement in Cellulite

Soliton’s Rapid Acoustic Pulse (RAP) device, which was cleared for tattoo removal in 2019, has received FDA clearance for short-term improvement in the appearance of cellulite. […]
February 3, 2021

FDA Recalls Subcutaneous-ICD Leads Due to Fracture Risk FDA Recalls Subcutaneous-ICD Leads Due to Fracture Risk

The US Food and Drug Administration (FDA) has issued a Class I recall of the electrode component of the EMBLEM S-ICD (Boston Scientific), the iconic subcutaneous […]
February 1, 2021

EU Panel Backs Icosapent Ethyl for CV Event Reduction EU Panel Backs Icosapent Ethyl for CV Event Reduction

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of icosapent ethyl to reduce the risk for cardiovascular (CV) […]
January 28, 2021

FDA OKs First Injectable Complete Drug Regimen for HIV FDA OKs First Injectable Complete Drug Regimen for HIV

The US Food and Drug Administration (FDA) has approved Cabenuva, an injectable formulation of cabotegravir (Vocabria) and rilpivirine (Edurant), for adults living with HIV-1 infection. Cabenuva […]
January 27, 2021

FDA Approves Voclosporin for Lupus Nephritis FDA Approves Voclosporin for Lupus Nephritis

The Food and Drug Administration has approved voclosporin (Lupkynis) for the treatment of lupus nephritis, according to a Jan. 22 press release from manufacturer Aurinia Pharmaceuticals. […]
January 26, 2021

USMLE Stuns Again: Clinical Skills Test Permanently Ended USMLE Stuns Again: Clinical Skills Test Permanently Ended

The Step 2 Clinical Skills (CS) test for medical school students and graduates has been permanently canceled, cosponsors of the US Medical Licensing Examination (USMLE) announced […]
January 20, 2021

FDA Approval Adds Vericiguat (Verquvo) to HF Treatment Options FDA Approval Adds Vericiguat (Verquvo) to HF Treatment Options

The list of pharmacologic options for patients with heart failure (HF) has lengthened again with US Food and Drug Administration approval of vericiguat as an addition […]
January 20, 2021

FDA Approves First and Only Treatment for AL Amyloidosis FDA Approves First and Only Treatment for AL Amyloidosis

The first and only treatment for a rare and often fatal blood cell disorder has been approved in the United States. The new indication is newly […]
January 14, 2021

FDA Clears First Rapid Handheld Blood Test for Concussion FDA Clears First Rapid Handheld Blood Test for Concussion

The US Food and Drug Administration (FDA) has approved the first rapid handheld blood test for suspected mild traumatic brain injury (TBI), the company has announced. The […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0